Anti-NCL-MycG4/G-quadruplex complex Antibody (NG14)

Title: Anti-NCL-MycG4/G-quadruplex complex Antibody (NG14): A Powerful Tool for Studying G-quadruplex Structures in Biotech Research

Introduction:
The Anti-NCL-MycG4/G-quadruplex complex Antibody (NG14) is a highly specific and sensitive antibody designed for the detection and analysis of G-quadruplex structures in biotech research. This unique antibody targets the NCL-MycG4/G-quadruplex complex, a key component in the formation and stabilization of G-quadruplex structures. With its exceptional specificity and sensitivity, NG14 is an essential tool for studying the role of G-quadruplexes in various biological processes.

Biological Function:
G-quadruplexes are four-stranded DNA structures that play a crucial role in various biological processes, including gene regulation, telomere maintenance, and DNA replication. The NCL-MycG4/G-quadruplex complex is a specific type of G-quadruplex that is formed by the interaction of the nucleolin (NCL) protein and the MycG4 DNA sequence. This complex is essential for stabilizing G-quadruplex structures and regulating their function. NG14 specifically targets this complex, making it a valuable tool for studying G-quadruplexes in biotech research.

Main Applications:
NG14 has a wide range of applications in biotech research, including:

1. Detection and analysis of G-quadruplex structures:
NG14 is highly specific for the NCL-MycG4/G-quadruplex complex, making it an ideal tool for detecting and analyzing G-quadruplex structures in various biological samples. Its sensitivity allows for the detection of even low levels of G-quadruplexes, providing researchers with valuable insights into their role in different biological processes.

2. Identification of G-quadruplex-binding proteins:
G-quadruplexes are known to interact with various proteins, and NG14 can be used to identify G-quadruplex-binding proteins and study their function. This can help in understanding the role of G-quadruplexes in gene regulation, DNA repair, and other biological processes.

3. Screening for G-quadruplex-targeting drugs:
The unique structure of G-quadruplexes makes them attractive targets for drug development. NG14 can be used to screen for potential G-quadruplex-targeting drugs, making it an essential tool for drug discovery in biotech research.

Experimental Use Cases:
To further illustrate the capabilities of NG14, here are some experimental use cases where this antibody has been successfully used:

1. Detection of G-quadruplex structures in cancer cells:
NG14 has been used to detect and analyze G-quadruplex structures in cancer cells, providing valuable insights into the role of these structures in cancer progression and potential therapeutic targets.

2. Identification of G-quadruplex-binding proteins in telomeres:
NG14 has been used to identify proteins that interact with G-quadruplex structures in telomeres, shedding light on the role of G-quadruplexes in telomere maintenance and aging.

3. Screening for G-quadruplex-targeting drugs in neurodegenerative diseases:
NG14 has been used to screen for potential G-quadruplex-targeting drugs in neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, where G-quadruplexes have been implicated in disease progression.

In conclusion, the Anti-NCL-MycG4/G-quadruplex complex Antibody (NG14) is a powerful tool for studying G-quadruplex structures in biotech research. Its exceptional specificity and sensitivity make it an essential tool for detecting and analyzing G-quadruplexes, identifying G-quadruplex-binding proteins, and screening for G-quadruplex-targeting drugs. With its diverse applications and successful use cases, NG14 is a must-have for any researcher studying G-quadruplexes in biotech research.